Q/C Technologies, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Q/C Technologies, Inc. (QCLS) had Deferred Tax Assets, Operating Loss Carryforwards of $29.45 million as of 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-04-15
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $29.45M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $27.87M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $26.49M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $26.18M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $29.45M 10-K · filed 2026-04-15 | |
| 2024-12-31 | $27.87M 10-K · filed 2026-04-15 | |
| 2023-12-31 | $26.49M 10-K · filed 2025-04-11 | |
| 2022-12-31 | $26.18M 10-K · filed 2024-04-01 | |
| 2021-12-31 | $23.53M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $21.51M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $19.20M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $18.42M 10-K · filed 2020-03-25 | |
| 2017-12-31 | $15.76M 10-K · filed 2019-04-01 | $15.66M 10-K · filed 2018-04-03 |
| 2016-12-31 | $21.62M 10-K/A · filed 2018-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |